Study Stopped
Recruitment inadequate
The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)
SaFR
1 other identifier
interventional
4
1 country
1
Brief Summary
This study tests the hypothesis that repeated inflation of a blood pressure cuff on the arm will improve results of coronary stent implantation by:
- reducing chest pain and electrocardiogram changes during balloon inflation to place the stent
- reducing leakage of heart muscle protein(troponin) into the blood stream after stent placement, indicated reduced damage to heart muscle during stent implantation
- increases in molecules in the blood that promote dilation of arteries
- reduced evidence of heart muscle damage on MRI immediately after stenting
- improved patient outcomes over six months with fewer adverse cardiovascular events(heart attack, acute coronary syndrome,renarrowing of the stented artery, heart failure, death, stroke, transient ischemic attack)
- improved heart structure and function at 6 months after stenting
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable coronary-artery-disease
Started Mar 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2010
CompletedStudy Start
First participant enrolled
March 1, 2010
CompletedFirst Posted
Study publicly available on registry
March 2, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedMarch 19, 2020
March 1, 2020
1.6 years
March 1, 2010
March 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MACE
MACE is defined as a combined endpoint including: heart attack, acute coronary syndrome,restenosis of the stented artery, new heart failure stroke, transient ischemic attack or death
6 months post-stenting
Secondary Outcomes (5)
troponin I
24 hours
chest pain during stenting
immediate during procedure
ST segment changes during stent implantation
immediate
MRI delayed enhancement
1-7 days after stenting
Late left ventricular volumes and ejection fraction
6 months
Study Arms (2)
Remote Ischemic Preconditioning (RIPC)
EXPERIMENTALRandomized subjects who are treated immediately prior to stenting with remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff inflations to occlude the brachial artery in their nondominant arms, with intervening 5 minute rest periods.
Sham Remote Ischemic Preconditioning
PLACEBO COMPARATORPatients who prior to stenting have the RIPC blood pressure cuff placed but not inflated for 3 5 minute episodes with 5 minute rest periods.
Interventions
Randomized subjects are treated immediately prior to stenting with remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff inflations to occlude the brachial artery in their nondominant arms, with intervening 5 minute rest periods.
Randomized subjects who are exposed immediately prior to stenting to sham remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff placements without inflation on their nondominant arms, with intervening 5 minute rest periods.
Eligibility Criteria
You may qualify if:
- Patients with stable chronic coronary artery disease scheduled for elective percutaneous intervention.
You may not qualify if:
- Recent (1 month) myocardial infarction
- Acute coronary syndrome
- Chest pain at res
- Estimated glomerular filtration rate(GFR)\<45 mL/min/1.73 m2
- Frequent premature atrial or ventricular contractions or atrial fibrillation
- Any contraindication to MRI including implanted non MRI compatible medical devices or ferromagnetic materials such as shrapnel
- Inability to breath-hold
- Severe claustrophobia
- Deafness
- Persistent tremor
- Inability to follow instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Francis Hospital-The Heart Center
Roslyn, New York, 11576, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathaniel Reichek, MD
St. Francis Hospital-The Heart Center, Roslyn, NY
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Research Department and Cardiac Imaging Program
Study Record Dates
First Submitted
March 1, 2010
First Posted
March 2, 2010
Study Start
March 1, 2010
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
March 19, 2020
Record last verified: 2020-03